Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Blog | January 03, 2012

NDCA clarifies that Marking turns on what claims are asserted, not what survives to trial

Blog | January 02, 2012

NDCA denies Daubert motion for Defendant's damages expert

Article | December 02, 2011

Orange Book Listing Opportunities for Drug-Device Combinations

Blog | December 01, 2011

WD TN Grants New Trial on Damages after Remand Because the Reasonable Royalty Rate in the Original Verdict Was Based on the Now-Defunct 25%

Article | November 08, 2011

Inspiration or infringement?: Examining the Janine Gordon v. Ryan McGinley Photography Case

Article | October 21, 2011

Is It Time for FDA to Revise Its Orange Book Rules to Deal with Skinny Labeled Generic Drugs?

Blog | October 19, 2011

EDTX Finds Duty to Mark Gift Cards (Alexsam v. Pier 1 Imports)

Blog | September 30, 2011

EDTX Awards Supplemental Damages (Pre- and Post-Verdict)

Blog | August 12, 2011

EDTX Issues Pretrial Rulings on Reasonable Royalty and Lost Profits Damages

Article | August 10, 2011

New FDA Draft Guidance Sheds Light On Regulation of 'Mobile Medical Apps' and Other Software

Blog | August 08, 2011

NDTX Strikes One License and Allows Another; Finds Fault in Expert's Use of Entire Market Value Rule

Blog | August 05, 2011

Oracle v. Google: NDCA Judge Alsup Rejects Nash Bargaining Solution and Grants Google's Motion to Exclude Oracle's Expert's Report and Testimony Advocating $1.4B to $6.1B in Damages